A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence

Citation

Boyce, Ross M.; Shook-Sa, Bonnie E.; & Aiello, Allison E. (2021). A Tale of 2 Studies: Study Design and Our Understanding of Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence. Clinical Infectious Diseases, 73(9), e3124-6. PMCID: PMC7799336

Abstract

The coronavirus disease 2019 (COVID19) pandemic is arguably the most important public health crisis of the last century. To date, infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus have caused nearly 300,000 deaths in the United States alone [1], while also contributing to substantial excess morbidity and mortality from delayed and deferred care [2]. In addition to the direct and indirect health effects, policies intended to limit the spread of the disease have resulted in large-scale disruptions to education systems, economic activity, and social networks. Put simply, the COVID-19 pandemic has affected the daily lives of nearly all Americans in a way that no other health crisis has in our lifetimes.

URL

http://dx.doi.org/10.1093/cid/ciaa1868

Reference Type

Journal Article

Year Published

2021

Journal Title

Clinical Infectious Diseases

Author(s)

Boyce, Ross M.
Shook-Sa, Bonnie E.
Aiello, Allison E.

Article Type

Editorial

PMCID

PMC7799336

Continent/Country

United States of America

State

Nonspecific

ORCiD

Boyce, R - 0000-0002-9489-6324
Aiello - 0000-0001-7029-2537